ARK Investment Management LLC

Holdings History for Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

Symbol: VERV
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

ARK Investment Management LLC ownership in Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV)

10 Jan 2025 - ARK Investment Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV). This represents 0% ownership of the company. This is the first filing by ARK Investment Management LLC disclosing ownership of Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ARK Investment Management LLC	0%		$0	0			$2.97	13G/A	30 Sep 2024	10 Jan 2025, 21:24

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.13%	$0	0	-2,936,063	-100%		Q3 2024
30 Jun 2024	0.13%	0%	$14,327,987	2,936,063	0		$4.88	Q2 2024
31 Mar 2024	0.56%	0%	$80,217,518	6,040,476	0		$13.28^*	Q1 2024
31 Dec 2023	0.58%	+0.19%	$97,930,110	7,025,116	+1,824,549	+35%	$13.94	Q4 2023
30 Sep 2023	0.53%	+0.01%	$68,959,525	5,200,567	+49,716	+0.97%	$13.26	Q3 2023
30 Jun 2023	0.64%	+0.08%	$96,578,455	5,150,851	+668,760	+15%	$18.75	Q2 2023
31 Mar 2023	0.44%	+0.01%	$64,631,752	4,482,091	+116,261	+2.7%	$14.42	Q1 2023
31 Dec 2022	0.73%	+0.16%	$84,478,811	4,365,830	+971,971	+29%	$19.35	Q4 2022
30 Sep 2022	0.83%	+0.33%	$116,579,000	3,393,859	+1,359,735	+67%	$34.35	Q3 2022
30 Jun 2022	0.18%	+0.03%	$30,837,000	2,034,124	+347,179	+21%	$15.16	Q2 2022
31 Mar 2022	0.16%	+0.03%	$38,496,000	1,686,945	+287,400	+21%	$22.82	Q1 2022
31 Dec 2021	0.16%	+0.01%	$51,601,000	1,399,545	+131,840	+10%	$36.87	Q4 2021
30 Sep 2021	0.14%	+0.06%	$59,582,000	1,267,705	+719,316	+131%	$47.00	Q3 2021
30 Jun 2021	0.06%	+0.07%	$33,040,000	548,389	+548,389	NEW	$60.25	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.